Previous 10 | Next 10 |
2024-05-07 13:59:04 ET Summary Hims & Hers Health, Inc. is leading in personalized health and building a strong health and wellness platform, leading to strong subscription growth. The company reported profitable growth in Q1 '24, with positive cash flows from adjusted profits...
2024-05-07 11:56:30 ET DENVER, Colo., May 07, 2024 ( 247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB ), Hims & Hers Health, Inc. (NYSE: HIMS ), Nuwellis (Nasdaq: NUWE ), Clearmind Medicine Inc. (Nasdaq: CMND ), and reAlpha Tech (Na...
2024-05-07 11:15:03 ET Seaport Global analyst issues BUY recommendation for HIMS on May 7, 2024 09:28AM ET. The previous analyst recommendation was Buy. HIMS was trading at $12.5514 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
2024-05-06 20:11:09 ET Hims & Hers Health, Inc. (HIMS) Q1 2024 Earnings Conference Call May 06, 2024, 05:00 PM ET Company Participants Bill Newby - Head, IR Andrew Dudum - Co-Founder and CEO Yemi Okupe - CFO Conference Call Participants Allen Lutz...
2024-05-06 16:54:48 ET More on Hims & Hers Health Hims & Hers Health: An Unforced Error Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation ...
2024-05-06 16:13:20 ET More on Hims & Hers Health Hims & Hers Health: An Unforced Error Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation ...
Revenue of $278.2 million, up 46% year-over-year in 2024 Net income of $11.1 million; Adjusted EBITDA of $32.3 million in Q1 2024 Subscribers grew to 1.7 million, up 41% year-over-year in Q1 2024 Raises full year 2024 guidance to a range of $1.20 billion to $1.23 billion a...
2024-05-06 14:05:07 ET Summary Hims & Hers Health, Inc. stock sold off five percent Friday after the CEO made some controversial remarks about current college protests. The shares are down some 20% over the past month, even as the company continues to post impressive sales gro...
PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....
2024-05-06 06:50:36 ET More on Hims & Hers Health Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation Hims & Hers: 5 Reasons Why This Is A P...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...